BioSpace News Archive

Softgel comprises a gelatin-based shell encompassing a semi-solid or liquid medication or concentrate filled inside it. Softgel capsules offer several advantages to customers, for example, easy usability, improved adequacy, and bioavailability.

Cigarette smoking is a chronic health problem across the globe. There has been increased focus on the adverse economic and health effects of smoking.

Ultrasound is a medical imaging technology that involves use of high-frequency sound waves to visualize the internal body organs.

Fainting caused by a fall in blood pressure is known as syncope in medical parlance. Its onset is swift and sudden and its duration is short with spontaneous recovery.

The growth of the global cervical dysplasia market can be attributed to advancements in female healthcare.

Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, announced the appointment of an additional member to its Board of Directors.

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, announces that the post-grant review period for granted U.S. Patent No. 10,696,730 ended on March 30, 2021.

Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system disorders, announced that the European Commission has granted Orphan designation for PBKR03, an adeno-associated virus -delivery gene therapy for the treatment of Krabbe disease.

ION363, the first medicine to specifically target FUS-ALS, is among Ionis’ wholly owned assets the company plans to commercialize

Conference to include interim results from the open-label extension of the PULSAR Phase 2 trial showing consistent or improved responses in efficacy endpoints among sotatercept-treated patients